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Aim: Puberty suppression by gonadotropin-releasing hormone analogues (GnRHa) is prescribed to relieve the distress associated with pubertal development in adolescents with gender dysphoria (GD) and thereby to provide space for further exploration. However, there are limited longitudinal studies on puberty suppression outcome in GD. Also, studies on the effects of psychological support on its own on GD adolescents’ well-being have not been reported. This study aimed to assess GD adolescents’ global functioning after psychological support and puberty suppression. 
Methods: 201 GD adolescents were included in this study and completed the Utrecht Gender Dysphoria Scale (UGDS), a self-report measure of GD related discomfort. In a longitudinal design we evaluated adolescents’ global functioning every 6 months from the first visit. We used the Children’s Global Assessment Scale (CGAS) to assess the psychosocial functioning of adolescents. 
Results: At baseline, GD adolescents showed poor functioning with a CGAS mean score of 57.7±12.3. GD adolescents’ global functioning improved significantly after 6 months of psychological support (CGAS mean score: 60.7 ± 12.5; P < 0.001). Moreover, GD 
adolescents receiving also puberty suppression had significantly better psychosocial functioning after 12 months of GnRHa (67.4 ±13.9) compared to when they had received only psychological support (60.9 ± 12.2, P = 0.001).


























Gender dysphoria (GD) individuals experience a marked incongruence between their assigned gender and their experienced gender [1]. GD refers to this stressful condition resulting in clinically significant distress or impairment in important areas of functioning [2; 3]. When supporting and treating children and adolescents with GD, health professionals should broadly conform to the Standards of Care of the World Professional Association for Transgender Health (WPATH) [4]. These guidelines indicate that psychological support should focus on exploring gender identity, role, and expression; addressing the negative impact of gender dysphoria and stigma on mental health; alleviating internalized transphobia; enhancing social and peer support; improving body image; promoting resilience. Psychological interventions such as individual, couple, family, or group therapy should be provided within a multidisciplinary gender identity specialty service [4].
Studies indicate that cross-sex hormonal treatment (CSHT) improves well-being in GD adults [5; 6]. However, it has been observed that despite many years of psychotherapy the GD of most adolescents doesn’t often abate. Rather, once these young persons, who are already experiencing considerable distress over their gender identity, undergo the pubertal development of their biological sex, their psychological well-being deteriorate significantly [7]. Because this risk can be so great, the need for an early intervention has become paramount. Delemarre-van de Waal and Cohen-Kettenis have proposed an early intervention approach, the Dutch model [8], which aims to eliminate the exposure to unwanted pubertal hormones, limit gender dysphoria, and improve the ability to 'pass' as the desired gender in adulthood. It considers adolescents, after a comprehensive psychological evaluation with many sessions over a longer period of time, eligible for puberty suppression, cross-sex hormonal treatment (CSHT), and gender reassignment surgery (GRS) at the respective ages of 12, 16, and 18 years when there is a history of GD; no psychosocial problems interfering with assessment or treatment; adequate family or other support; and good comprehension of the impact of medical interventions. According to this protocol, suppressing puberty and allowing young individuals the opportunity to explore their gender identity would provide some relief from the distress associated with the development of secondary characteristics [8]. Consistently, some studies indicate that puberty suppression leads to a better psychosocial outcome [2; 9].
Since the release of the Dutch model, there has been disagreement about the appropriateness of treatment in minors. Some practitioners have questioned the ethics and safety of this intervention. Conversely, other health care professionals have argued they have an obligation to alleviate suffering and it would be unethical to allow a patient to suffer through the distress of pubertal development when there is a way of preventing it [10]. Anyway, puberty suppression by gonadotropin-releasing hormone analogues (GnRHa) has increasingly become accepted in clinical management of adolescents with GD.  Even if further studies are needed, GnRHa are considered a safe and putatively reversible intervention which should be provided to people in need of it, especially if allowing puberty to progress appears likely to harm the young person [7].













Study design and participants
This longitudinal study was conducted at the Gender Identity Development Service (GIDS) in London. The health care pathway provided at the GIDS is described in Figure 1. A consecutive series of 436 adolescents (mean age = 15.74 ± 1.38 years; natal male/natal female ratio = 1:1.7) were referred between 2010 and 2014 to the GIDS. 201 adolescents (mean age = 15.52 ± 1.41 years; natal male/natal female ratio = 1:1.6) completed the diagnostic procedure (about 6 months) and were invited to take part in the follow-up evaluations. No GD adolescent refused to participate and all participants and their parents gave informed consent. By clinical interview, all adolescents fulfilled DSM-IV-TR criteria in use at the time for Gender Identity Disorder. The GIDS has adopted the WPATH Standards of Care [4]. There were no significant differences in socio-demographic characteristics as well as baseline CGAS scores between adolescents with a GD diagnosis enrolled in this study (N = 201) and adolescents who did not complete the diagnostic procedure (N = 235; all P > 0.1). 

Psychological support
	The GIDS has developed a standardized psychological assessment which is part of the diagnostic procedure, in accordance with the WPATH guidelines [4]. This model emphasizes the early recognition and non-judgmental acceptance of gender identity problems as well as the importance of ameliorating associated behavioural, emotional and relationship difficulties [11]. Ample room is given to adolescents to explore different options for gender expression. Together with their families GD adolescents are supported in making difficult decisions regarding the extent to which they are allowed to express a gender role that is consistent with their gender identity. Also the timing of changes in gender role and possible social transition are extensively explored. This ensures that decisions about gender expression and the treatment of GD are thoughtfully and recurrently considered. Health care professionals help families to make decisions regarding the timing and process of any gender role changes for their young children. Information is provided to parents to weigh the potential benefits and challenges of choices.
The aims outlined are achieved through various psychotherapeutic interventions, ranging from individual to family and group therapy, which are carried out on a regular basis (at least once a month). Social and educational interventions are also provided if necessary. All these interventions are well coordinated and integrated in a comprehensive management plan agreed with local services (The Network Model). Moreover, the care pathway provides continuous psychological support to the patients’ emotional and behavioural changes that may occur during the puberty suppression treatment. All adolescents received psychological support for the entire duration of the study.

Eligibility for puberty suppression










The data collected included: natal gender (male-female ratio), age (at assessment, at start of GnRHa), education level (yes/no), living arrangement (both parents, one parents, other), living in the chosen gender (partly, i.e. by wearing clothing and having a hairstyle that reflects gender identity/completely, i.e. by also using a name and pronouns congruent with gender identity/no), and change of name (yes/no). 

Gender Dysphoria related discomfort
The Utrecht Gender Dysphoria Scale (UGDS) was used to measure adolescents’ GD related discomfort. This is a 12-item questionnaire specifically developed to measure GD in a dimensional way. In particular, the UGDS focuses on core aspects of GD and gender identity. The adolescents are asked to rate their agreement on a 5-point scale. The total score ranges from 12 to 60. Higher UGDS total scores indicate high level of GD [13]. The scale has shown a high reliability (a Cronbach’s alpha of .66–.80 in one sample, and .78–.92 in another); as reported by the authors, the lower alphas on the scale were only found among control subjects, which may be related to the lower variability of GD in these groups [13]. Cronbach’s alpha for UGDS in our sample was .76–.88. The UGDS has also shown a good discriminant validity, when adolescents and adults with and without a GD diagnosis were compared.  

Measure of global psychosocial functioning    
The Children’s Global Assessment Scale (CGAS) was used to assess adolescents’ psychosocial functioning. The CGAS is one of the most widely used rating scales designed to measure how children and adolescents function psychosocially in daily life [14]. This clinical-rated instrument is divided into 10-points intervals and ranges from 1 to 100, with higher scores indicating better psychosocial functioning. The CGAS is useful to assess psychosocial/psychiatric outcomes, socio-cognitive competence and changes due to treatment [15]. In particular, it has been used in several longitudinal and epidemiological studies in clinical and non-clinical populations, naturalistic cohorts [16] and young GD individuals [9]. The inter-rater reliability was tested by Shaffer and his colleagues [14] before publication of CGAS, in order to minimize variation due to clinician background. Test-retest has been described in different studies with raters’ consistence over time [16]. 
All CGAS were administered by qualified psychologists, psychotherapists, and psychiatrists who attended training and intra-class correlation assessment (.76 ≤ Cronbach’s α ≤ .94). Participants were assessed at baseline (Time 0) and every following 6 months, for a total of 4 evaluations over a 18-month period. Follow-up evaluations were performed six months from the baseline (Time 1: after 6 months of psychological support); 12 months from the baseline (Time 2: after 12 months of psychological support for delayed eligible GD adolescents, and after 12 months of psychological support + 6 months of puberty suppression for immediately eligible GD adolescents); 18 months from the baseline (Time 3: after 18 months of psychological support for delayed eligible GD adolescents, and after 18 months of psychological support + 12 months of puberty suppression for immediately eligible GD adolescents). 

Statistical Analysis 
Chi-square and independent t-tests were used to test for possible differences in socio-demographic characteristics and CGAS scores between natal males and natal females; adolescents who didn’t complete the diagnostic procedure and adolescents who received a GD diagnosis; immediately eligible and delayed eligible individuals. Dependent and independent t-tests were used to test for possible differences in CGAS scores between baseline and follow-up evaluations, in both immediately eligible and delayed eligible individuals. 
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Socio-demographic characteristics of the sample
Socio-demographic characteristics of the sample (N = 201) are reported in Table 1. The majority of GD adolescents were living with one parent, were in education, were living as a member of the desired gender, and had changed their names. However, compared to natal females, a higher proportion of natal males did not live with their biological parents, had left school, were not living as a member of the desired gender, and had not changed their names. Moreover, natal females reported a significantly higher gender dysphoria related discomfort than natal males. Natal males and females did not differ in their age, both at assessment and when GnRHa was started (Table 1). 

CGAS at baseline
GD adolescents’ CGAS at baseline (Time 0, M=57.7 ± 12.3) revealed a score suggestive of “variable functioning with sporadic difficulties or symptoms in several but not all social areas” (range 50-59). Natal males had a significantly lower functioning than natal females at baseline (P = 0.03; Table 1). CGAS scores were not associated with any demographic variable, in both natal males and females (all P > 0.1). 

CGAS at follow-up
Compared with baseline, GD adolescents’ psychosocial functioning was increasingly higher at each of the following evaluations (Figure 2). In particular, CGAS scores were significantly higher after 6 months of psychological support (Time 0 vs Time 1, P < 0.001). Also there was a further significant improvement 18 months from baseline (Time 1 vs Time 3, P = 0.02; Table 2).
Delayed eligible GD adolescents, who received only psychological support for the entire duration of the study, had a significantly better psychosocial functioning after six months of psychological support (time 0 vs time 1, P = 0.05). However, despite scoring better at the following evaluations they did not show any further significant improvement in their psychosocial functioning (Table 2). On the contrary, the immediately eligible group, who at baseline had a higher but not significantly different psychosocial functioning than the delayed eligible group, did not show any significant improvement after six months of psychological support. However, immediately eligible adolescents had a significantly higher psychosocial functioning after 12 months of puberty suppression compared to when they had received only psychological support (Time 1 vs Time 3 P = 0.001; Table 2). 










Results from this study indicate that psychological support is associated with a better psychosocial functioning in GD adolescents, especially if presenting psychological/psychiatric problems. Moreover, puberty suppression was associated with a further improvement in global functioning. Finally, global functioning improved steadily over time in GD adolescents receiving both psychological support and GnRHa.
Medical and surgical interventions are considered to be necessary components of effective management in GD adults. These partially reversible/ irreversible treatments aim to align the individuals’ physical appearance with their internal gender identity and have been shown to improve the patients’ psychosocial well-being [3; 5; 6]. GD adolescents may experience psychosocial problems at puberty onset due to an intensification of feelings of incongruence between self-perception and their natal gender [2; 9]. Therefore, in the pre-pubertal population, the suppression of puberty using continuous gonadotropin-releasing hormone agonists (GnRHa) is a fully reversible treatment which has the fundamental benefit for children of gaining time to reflect over their gender identity, have a real-life experience living as the other gender (i.e., in dress and behavior) and determine whether or not they desire the transition [12; 13]. Preventing the development of a body contrary to the experienced gender, puberty suppression allows GD adolescents to experience a smooth transition into their desired gender role. This translates into an improvement in many aspects of their psychosocial functioning, such as mood improvement and school integration [2; 9]. Consistently, these results underline the importance of puberty suppression for GD adolescents’ well-being.  
The GD adolescents’ improved global functioning after only 6 months of psychological support may have different explanations. First, it could indicate that the timely addressing of psychosocial problems contributes to enhanced psychological well-being. Second, as also reported in previous studies among both GD adults and adolescents [2; 3; 5; 9], our clinical experience suggests that patients attending a gender unit are pleased in the knowledge that the puberty suppression will be performed within a reasonable time and refer a distress reduction because of their accepted and understood requirements. Moreover, the initiation of the puberty suppression may have a psychological meaning which per se could be fundamental in reducing distress. In any case, data are too limited to express conclusively. 
Both natal males and females benefited from the clinical approach, although natal males had a significantly worse functioning than natal females at baseline. It is even more important if we consider that natal males reported more social difficulties than natal females (higher drop-out from school and more frequently not living with their parents). Interestingly, natal females reported significantly more GD related discomfort than natal males. As already suggested [2], with a mean of 15 years most natal females had developed their breasts and had their menarche, which are likely to be associated with higher levels of distress. Therefore, natal males and females may need to be thought about separately and may require different interventions. Also, as the revised Dutch model [8] encourages considering GD individuals eligible for puberty suppression when they are 12 years old, studies are ongoing at our service to explore the possible benefit of further reducing the age for being eligible for puberty suppression. 
A recent research has assessed the psychosocial functioning in a sample of young individuals without observed psychological/psychiatric symptoms representative of the general population (N=169), using the same methodology of this study, the CGAS scale [16]. This sample was part of a large naturalistic cohort of children/adolescents who attended child and adolescent mental health services (CAMHS; N=12613) in Stockholm. The authors find that this nonclinical sample has a CGAS score suggestive of good psychosocial functioning (67.1 ± 12). In our study GD adolescents’ psychosocial functioning at baseline is significantly worse (t = 7.4, P < 0.001) than that found in this sample of children/adolescents without observed psychological/psychiatric symptoms. Moreover, comparing the delayed eligible GD individuals with this nonclinical sample we find that delayed eligible GD individuals continue to have a significantly worse psychosocial functioning even after 18 months of psychological support (Time 3, t = 2.0, P = 0.04). Instead, the immediately eligible GD individuals’ CGAS scores after 12 months of puberty suppression (Time 3) coincide almost perfectly with those found in the nonclinical sample (t = 0.01, P = 0.99). Even if the absence of a control group in our study doesn’t allow expressing conclusively on these comparisons, GD adolescents undergoing puberty suppression in addition to the psychological support result in psychosocial functioning levels that are impossible to differentiate from a sample of peers. These additional findings further indicate the effectiveness of both psychological support and puberty suppression in enabling young GD individuals to reach a satisfactory psychosocial functioning.
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